Treatment Efficacy [qlco]
Anti-Hypertensive Drugs [phsu]
Combination [qlco]
Atom [elii]
Review, Systematic [inpr]
Meta-Analysis [inpr]
randomized [resa]
Clinical Trials [resa]
prisma [orch, phsu]
Statement [idcn]
Background [cnce]
Relative [famg]
Efficacy [qlco]
Anti-Hypertensive Drugs [phsu]
Combinations [mnob]
Not Known [qlco]
Well [qlco]
Most [qnco]
effective [qlco]
One [qnco]
Patients [podg]
Characteristics [qlco]
Associated [qlco]
Best [qlco]
Performance [inbe]
Drugs [phsu]
Management [ocac]
hypertensive [fndg]
Patients [podg]
Objective [inpr]
To [qlco]
Assess [acty]
Blood Pressure [orgf]
reduction [npop]
Attribute [idcn]
Anti-Hypertensive Drugs [phsu]
Characteristics [qlco]
Associated [qlco]
Blood Pressure [orgf]
Decrease [qlco]
Data Sources [qnco]
MEDLINE [inpr]
Central [spco]
Controlled [ftcn]
Trial [resa]
Select [acty]
Papers [mnob]
Study Eligibility Criteria [qlco]
DOUBLE BLIND [resa]
Clinical Trials, Randomized [inpr, resa]
Main [qlco]
Result [ftcn]
reduction [npop]
Blood Pressure [orgf]
Antihypertensive [phsu]
treatment [ftcn]
Study Population [popg]
Study [mnob]
cross over [genf]
Follow-up [fndg]
weeks [tmco]
Available [ftcn]
Required [ftcn]
Data [idcn]
Study [mnob]
synthesis [biof]
Methods [inpr]
Study [mnob]
Data [idcn]
Extracted [topp]
Multiple [qnco]
observers [prog]
introduce [ftcn]
Database, Electronic [inpr]
Inconsistent [qlco]
Resolved [idcn]
Discussion [topp]
Referral [hlca]
Back [blor]
Original [idcn]
Article [inpr]
Meta-Analysis [inpr]
Performed [ftcn]
prisma [orch, phsu]
Statement [idcn]
Using [ftcn]
Main [qlco]
Outcome [ftcn]
Measure [qnco]
Mean [qnco]
Decrease [qlco]
Systolic [tmco]
sbp [diap]
Diastolic blood pressure [clna]
Drug [phsu]
Combination [qlco]
Result [ftcn]
Two [qnco]
Eight [qnco]
Trial [resa]
Including [ftcn]
Patients [podg]
Identified [qlco]
Drugs [phsu]
Hg [elii, hops]
sbp [diap]
Hg [elii, hops]
Diastolic blood pressure [clna]
decreases [qnco]
olmesartan [orch, phsu]
Amlodipine [orch, phsu]
olmesartan [orch, phsu]
Hydrochlorothiazide [orch, phsu]
FELODIPINE/METOPROLOL [patf]
valsartan [orch, phsu]
Hydrochlorothiazide [orch, phsu]
Combinations [mnob]
Leading [tmco]
Greatest [qnco]
Mean [qnco]
sbp [diap]
reductions [npop]
Hg [elii, hops]
female sex [fndg]
Body Mass Index [diap]
M NOS [aapp, imft]
Associated [qlco]
More [ftcn]
sbp [diap]
Diastolic blood pressure [clna]
reductions [npop]
Afro American [popg]
Ethnicity [popg]
Associated [qlco]
Blood Pressure [orgf]
reductions [npop]
Smaller [qlco]
median [spco]
Result [ftcn]
Adjusted [ftcn]
Study duration [tmco]
Cardiovascular disease [dsyn]
Diabetes Mellitus [dsyn]
estimation [menp]
Performed [ftcn]
Using [ftcn]
Mean [qnco]
Administered [ftcn]
Dose [qnco]
Not [ftcn]
match [resa]
available drug [fndg]
formats [inpr]
limitations [ftcn]
Data [idcn]
Obtained [ftcn]
included [ftcn]
Trial [resa]
Analysis [lbpr]
Combinations [mnob]
Limited [ftcn]
Most Recent [tmco]
One [qnco]
estimations [menp]
Performed [ftcn]
Using [ftcn]
Mean [qnco]
Administered [ftcn]
Dose [qnco]
Conclusions [idcn]
Certain [qlco]
Drug Combinations [phsu]
Blood Pressure [orgf]
reductions [npop]
Range [qnco]
Sex [orgf]
Ethnicity [popg]
Obesity [dsyn]
Associated [qlco]
Antihypertensive [phsu]
Response [orga]
This [euka]
Information [idcn]
Contribute [acty]
To [qlco]
Better [qlco]
Antihypertensive drug [phsu]
depend [medd]
magnitude [qnco]
Pretreatment [sbst]
Blood pressure elevation [fndg]
Guidelines [inpr]
Revised [topp]
